Novo Nordisk A/S (NVO) vs Invesco QQQ Trust, Series 1 (QQQ)
Over the past 10 years, NVO lagged QQQ — 7.59% vs 20.40% annualized total return (price plus dividends).
A side-by-side comparison of Novo Nordisk A/S and Invesco QQQ Trust, Series 1 across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.
Total return — NVO vs QQQ
growth of $100 · dividends reinvested · last 27yMetrics side by side
Did NVO beat QQQ?
Over the past 10 years, NVO lagged QQQ — 7.59% vs 20.40% annualized total return (price plus dividends).
Total return (annualized)
| Metric | NVO | QQQ |
|---|---|---|
| Total return (1Y) | 4.60% | 22.37% |
| Total return CAGR (3Y) | -14.22% | 22.18% |
| Total return CAGR (5Y) | 2.46% | 14.22% |
| Total return CAGR (10Y) | 7.59% | 20.40% |
QQQ is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has NVO beaten QQQ?
- Over the past 10 years, NVO lagged QQQ — 7.59% vs 20.40% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.